Welsis (WLSS) Return on Sales (2022 - 2024)

Welsis (WLSS) posted quarterly Return on Sales of 0.46% for Q3 2024, down 48.0% year-over-year from 0.89% in Q4 2023, and down 2436.81% quarter-over-quarter from 0.02% in Q2 2024.

Welsis (WLSS) Return on Sales (2022 - 2024) Analysis & Trends

Welsis' Return on Sales history runs 3 years deep, the most recent figure standing at 0.46% for Q3 2024.

  • In Q3 2024, Return on Sales fell 48.0% year-over-year to 0.46%; the TTM figure through Sep 2024 stood at 0.46% (down 44.0% YoY), while the FY2024 annual figure was 0.46%, down 45.0% from the prior year.
  • Return on Sales for Q3 2024 stood at 0.46%, down from 0.02% in the prior quarter.
  • The five-year high for Return on Sales was 0.01% in Q3 2023, with the low at 0.46% in Q3 2024.
  • The 3-year median for Return on Sales is 0.05% (2022), against an average of 0.13%.
  • Peak annual rise in Return on Sales reached 22 bps in 2024, while the deepest fall reached 48 bps in 2024.
  • Welsis' Return on Sales stood at 0.03% in 2022, then tumbled by 695 bps to 0.21% in 2023, then sank by 122 bps to 0.46% in 2024.
  • Business Quant data shows WLSS's Return on Sales at 0.46% in Q3 2024, 0.02% in Q2 2024, and 0.02% in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 0.00%
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 0.00%
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 0.00%
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 0.00%
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 0.00%
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 0.00%
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 0.00%
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 0.00%
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 0.00%
10 Welsis 1.65 Mn 1.65 Mn - -

Historic Data

Download Data
DateValue
Sep 30, 2024 -0.46%
Jun 30, 2024 -0.02%
Mar 31, 2024 -0.02%
Dec 31, 2023 -0.21%
Sep 30, 2023 0.01%
Jun 30, 2023 -0.07%
Mar 31, 2023 -0.24%
Dec 31, 2022 -0.03%